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Available online at www.sciencedirect.comWhy do we need to sleep? What regulates when we sleep? And
what dictates the number of hours we require? These are often
viewed as three separate biological questions. Here, we
propose they share molecular etiologies, whereby regulators of
sleep schedules and sleep duration also govern the
physiological purposes of sleep. To support our hypothesis, we
review Mendelian human genetic variants sufficient to advance
sleep-wake onset (PER2) and shorten sleep length (DEC2), and
evaluate their emerging roles in immune responses that may
rely on a sound night of slumber.
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Introduction
Sleep is an innate behavior that is evidently circadian for
modern humans because it is usually a daily, consolidated
event with predictable timing. Quality of sleep is of
utmost importance, but it remains difficult to define
because its purpose is highly debated in light of many
intriguing possibilities [1,2]. Besides restorative biological
processes, optimal sleep in conventional society also takes
into account its timing (i.e. sleep schedules relative to the
time of day, also known as Process C due to its association
with circadian rhythmicity) and its duration (i.e. the
number of hours that yield satiety, also known as sleep
homeostasis or Process S) (Figure 1a) [3]. Sleep disorders
such as insomnia or sleep deprivation distort the relation-
ship between Processes C and S and affect both
(Figure 1b). Other variations in sleep patterns include
those that specifically affect Process C such as advancedwww.sciencedirect.com sleep phase (where affected individuals feel sleepy in the
late afternoon and wake up before sunrise, though the
total amount of sleep remains conventional) (Figure 1c),
and those that perturb only Process S such as natural short
sleep (Figure 1d) [4]. Therefore, understanding the bio-
logical underpinnings of Processes C and S may lead to
targeted treatment for sleep disorders.
It is a common belief that there are separate molecular
pathways for Processes C and S, and there may be coordi-
nated mechanisms between them that together ensure
‘optimal’ sleep quality. Therefore, the molecular basis of
the two-process model is sometimes simplified as a Venn
diagram with two partially intersecting circles (Figure 2a).
Process C is better understood compared to Process S
because it is associated with the ‘molecular core clock,’
which defines a series of mechanisms that allow a cell to
maintain circadian rhythmicity. The most defined aspects
of the molecular core clock are a series of transcription-
translation negative feedback loops that take approxi-
mately 24 hours to complete [5,6]. But despite a remark-
able correlation between cellular and behavioral circadian
periods (the time it takes to complete one cycle) [7], it is not
clear how the molecular core clock regulates timing of
sleep onset and offset. The molecular basis of Process S is
even more nebulous because it is challenging to define and
assay sleep homeostasis in vitro. Therefore, identifying
molecular components sufficient to alter sleep timing and
duration is of high research interest.
Through the identification of Mendelian human sleep
traits, genetic mutations that result in advanced sleep
phase (PER2) and shortened sleep duration (DEC2) were
found [8–10]. With regard to the two-process model,
PER2 appear to participate in Process C and DEC2 in
Process S. Interestingly, emerging evidence suggests an
intimate relationship between Processes C and S, and
clinical outcomes related to immune responses. Is it
possible that instead of directly sharing molecular mech-
anisms, Processes C and S may instead coordinate
through participating in physiological reasons for sleep
such as immune function? Here we posit that PER2 and
DEC2 may function as regulators of sleep timing and
duration respectively, yet both simultaneously impact the
immune system via separate mechanisms (Figure 2b).
Together, this hypothesis explains the observed corre-
lation between sleep and immune responses, and also
supports an alternative view of the two-process model.
Finally, we discuss the challenges of untangling the
molecular basis of sleep regulation (how much sleepCurrent Opinion in Neurobiology 2013, 23:873–879
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the consequences (or feedback) of impaired sleep on
molecular mechanisms underlying Processes C and S.
Human genetics of sleep timing and duration
The first Mendelian human circadian rhythm trait charac-
terized was Familial Advanced Sleep Phase (FASP), a
highly penetrant autosomal dominant trait [8,11].
Affected individuals awaken and go to bed exceptionally
early to maintain a normal quantity and quality of sleep,
and attempts at modifying circadian tendencies (such as
the use of phototherapy) are usually unsuccessful [12,13].
This advancement in sleep phase is accompanied by a
shortening of free-running activity period, which
measures the endogenous behavioral sleep-wake cycle
in the absence of environmental cues such as light, food
timing, and social interaction [11,14].
Using human genetic methods, it was determined that
PER2-S662G is associated with FASP in this pedigree.
To demonstrate that PER2-S662G is sufficient to advance
sleep timing, BAC transgenic mice carrying PER2-S662G
and PER2-S662D were generated, with the latter
mimicking phospho-serine at the same site because
S662 was hypothesized to be a phosphorylation site.
Remarkably, PER2-S662G mice recapitulate advanced
activity onset and shorter free-running period observed in
FASP individuals, whereas PER2-S662D mice demon-
strate longer free-running periods [9]. Further supporting
the importance of PER2 phosphorylation in sleep timing,
an additional genetic variant identified for FASP is
located in CSNK1D, which reduces enzymatic activity
and therefore hypophosphorylates PER2 in vitro [15,16].
In addition, constitutive expression of PER2 reversibly
disrupts circadian rhythms of activity [17].
Together, these findings suggest that the circadian oscil-
lation of PER2 may be sufficient for regulating sleep
timing [6]. However, FASP individuals do not exhibit
overt changes in Process S according to EEG measures of
sleep architecture [11]. In addition, Per2 knockout (KO)
mice are reported to exhibit no significant differences in
sleep homeostasis [18], suggesting that PER2 may be
responsible for only Process C. But since PER2 and
CSNK1D mutations appear to be sufficient for advancing
sleep phase and transmit in a Mendelian manner, it was
hypothesized that a rare genetic variant that changes
sleep duration may also exist. Indeed, Familial Natural
Short Sleepers (FNSS) were found to sleep 6–6.5 hours(Figure 1 Legend) The Integration of Process C and Process S. Figure not dr
process model of sleep as described by [3] integrates the daily (circadian) o
propensity accumulated in the awake state and relieved by restorative sleep
unaltered in the setting of sleep deprivation. (b) A model of sleep integration
increased dys-synchrony between the two-processes and reconciliation of s
line) over normal (dashed line) and Process S is unperturbed. (d) A model of in
and Process C is undisturbed. Blue bars, sleep. White bars, sleep deprivati
www.sciencedirect.com per night (2 hours less than controls), and they do not
report a sense of sleep deprivation. These FNSS indi-
viduals carry a mutation in DEC2/BHLHE41, which
encodes a transcription repressor that belongs to the
Hairy/Enhancer of Split subfamily [19]. The mutation
replaces a proline at position 384 with arginine, and BAC
transgenic mice carrying DEC2-P384R exhibit altered
sleep homeostasis. Specifically, DEC2-P384R mice
undergo shorter duration of rapid eye movement
(REM) (2%) and non-REM (NREM) (6%) sleep,
and recover more readily from sleep deprivation.
Together, these findings suggest that DEC2-P384R is
sufficient for reducing sleep length [10].
How does the DEC2-P384R mutation reduce sleep
quantity? Early evidence suggests that DEC2 participates
in the molecular core clock, but it is unclear whether
circadian molecular mechanisms are responsible for its
effects on sleep quantity [20–22]. P384R is located in a
novel proline-rich domain with no known circadian func-
tion. In addition, unlike PER2-S662G, neither DEC2-
P384R nor Dec2 KO mice demonstrate a change in free-
running period of activity [10,23]. These findings suggest
that at least on a behavioral level, sleep quantity and
timing are separate processes. In addition, the evidence
presented so far seems to suggest that PER2 regulates
sleep timing through the molecular core clock, whereas
DEC2 alters sleep duration through other pathways that
require further investigation. Therefore, Processes C and
S may not directly share molecular mechanisms respon-
sible for co-regulating sleep timing and duration. How-
ever, recent studies demonstrate a clinical correlation
between sleep and immune responses. Perhaps PER2
and DEC2 both exert distinct effects on immune
responses, resulting in co-regulation of a potentially
important function of sleep? To address this possibility,
we explore immune-related roles of PER2 and DEC2 in
the next section.
Genes that make you tick can make you sick
While there are numerous studies aimed at understanding
circadian effects on metabolism, cardiovascular function,
and other physiological processes, similar research for
immunological responses is just beginning to emerge
[5,24]. Clinical observations suggest that the time of
day influences susceptibility to disorders of human immu-
nologic activity, which implies that circadian molecular
mechanisms may regulate immune function. For
example, the risk of mortality in human patients sufferingawn to scale to emphasize theoretical changes. (a) The hypothetical two-
scillation of sleep propensity (Process C) with the homeostatic sleep
 (Process S). This model of integration assumes that Process C is
 whereby sleep deprivation also alters Process C (purple line) causing
leep need. (c) A model of integration where Process C is advanced (red
tegration where homeostatic sleep component of Process S is shortened
on.
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Molecular basis for the two-process model of sleep regulation. (a) The two-process model has been and remains instrumental for understanding the
dynamics of sleep regulation, and recent research is focused on finding molecular correlates for these processes, with an implicit assumption that
there are shared molecular mechanisms as well as separate pathways. (b) Our proposed model for understanding the purposes and regulation of sleep
based on the two-process model [3]. Recent evidence suggests that PER2 and CSNK1D may be sufficient to alter sleep onset-offset timing, and DEC2
may be sufficient to reduce sleep duration and modify sleep architecture by reducing NREM sleep more than REM sleep. Emerging findings point to
additional roles for PER2 and DEC2 in various aspects of immune function, which may contribute to the physiological purposes of sleep.from sepsis is increased between the hours of 2 am and
6 am [25]. Some rheumatic arthritis and asthma patients
experience daily cyclical variations in the severity of
symptoms [26–29]. Similarly, changes in sleep quantity
can interfere with appropriate immunologic responses.Current Opinion in Neurobiology 2013, 23:873–879 For instance, adults with short sleep duration had lower
secondary antibody responses to Hepatitis B vaccine,
resulting in decreased predicted clinical protection
[30]. In turn, this observation is associated with increased
T lymphocyte activation and reduced natural killer (NK)www.sciencedirect.com
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sleep timing or duration and some aspects of immune
function may be regulated by common molecular mech-
anisms.
PER2 and DEC2 appear to be sufficient for altering sleep
timing and duration respectively, and these proteins are
recently implicated in immune processes, potentially one
of the many purposes for sleep. Indeed, Per2 KO mice
demonstrate resistance to endotoxemic shock compared to
wild-type mice after intraperitoneal injection with lipopo-
lysaccharide (LPS) [32], and this finding is attributed to
reduced oscillations and absolute quantities of IFN-g and
IL-1b cytokines. Furthermore, peritoneal macrophages of
Per2 KO mice downregulate the expression of Toll-like
receptor 9 (TLR9), a pattern recognition receptor that
participates in both innate and adaptive immunity. When
challenged with TLR9 agonist, peritoneal macrophages
from Per2 KO animals had reduced IL6 and TNFa pro-
duction in vitro. These effects likely involve the molecular
core clock, because in vivo challenges of wild-type mice
performed at the peak of TLR9 oscillation revealed
increased morbidity and mortality [33].
Supporting the involvement of the molecular core clock
in immune responses, other core clock components are
also implicated to regulate inflammatory potential. When
injected with LPS, both systemic Rev-Erba KO and
macrophage restricted Bmal1 KO mice had elevated
cytokine production by abolishing the robust time-sensi-
tive generation of IL-6 compared to controls [34].
Macrophages from Cry1/2 double KO mice have increased
nuclear factor kappa B (NF-kB) activity, causing elevated
baseline cytokine expression in vitro and generating
greater inflammation when challenged with LPS in vivo
[35]. In addition, in the absence of Clock, T cells fail to
proliferate in a circadian manner [36]. As many immune
relevant transcription factors, such as members of the
signal transducer and activator of transcription family
(STATs) and NF-kB, also fall in the domain of circadian
regulation, it is likely that the molecular core clock drives
downstream activities of immune responses, with PER2
responsible for a subset that remains to be fully eluci-
dated [37].
Similar to PER2, DEC2 also exerts influences on immune
function. Specifically, DEC2 is involved in the matu-
ration of T helper type 2 (TH2) cell lineages associated
with humoral (antibody mediated) immunity. TH2 cells
highly express DEC2 compared to other T-cell lineages
[38,39]. Dec2 KO mice demonstrate defective TH2
responses after repeated stimulation with OVA peptide,
decreased alveolar infiltrate and reduced TH2 cytokine
production after exposure to an in vivo model of allergic
asthma [39]. DEC2 overexpression in undifferentiated
T cells drives a TH2 cell polarization while in vivo
allergic asthma challenges yield increased TH2 cytokinwww.sciencedirect.com production and increased lung interstitial infiltrate com-
pared to WT animals [38]. To our knowledge however,
there are no current studies addressing the effect of Dec2
on TH2 cell populations or the larger immune system in
the context of circadian timing or, more relevantly, dis-
tortion of sleep length. As DEC2 has been shown to affect
pathways as diverse as cellular proliferation, differen-
tiation, apoptosis and responses to hypoxia, DEC2 may
exert its effects on the immune system and sleep duration
outside of the molecular core clock. Further research is
necessary for defining pathways downstream of DEC2,
and it will be interesting to see whether DEC2-P384R
confers beneficial or detrimental immune outcomes in
addition to its role in reducing sleep duration.
Our hypothesis assumes that one of the main purposes of
sleep is immune-related, and most findings that investi-
gate the relationship between sleep and immune
responses do so through disrupting sleep. Transcriptome
based analysis of human subjects after sleep deprivation
(disruption of Processes C and S) reveal significant
changes in multiple immune related pathways
[40,41]. Supporting these findings, sleep deprivation
in animal models decreases circulating lymphocyte popu-
lations, reduces the cellularity of the spleen and bone
marrow [42,43], and acutely elevated inflammatory mar-
kers [44]. Simulated jet-lag models (which attempt to
mimic disruptions of Process C) altered coordinated
rhythmic expression of cytolytic factors and cytokines
in NK cells, leading to deficient cytolytic function
[45] and markedly decreased survival after LPS injection
[46]. Interestingly, when compared to control, a group of
genes that maintain circadian oscillation after sleep depri-
vation were explicitly immune related, hinting at the
critical nature of circadian immune regulation since they
are relatively preserved [41]. Together, these findings
support a correlation between sleep and immune func-
tion, and we conclude with a further discussion of this
association in relation to our hypothesis.
Conclusions
Although it is difficult to study both adaptive and innate
immune responses simultaneously, it is plausible that
Process C has a broader effect on immunity encompassing
both adaptive and innate functions, whereas Process S
may more specifically affect adaptive immunity and T
cell polarization. Sleep deprivation with its effect on both
Processes C and S would then encompass the broadest
range of immune alteration. However, even though these
data allude to a hierarchical model for sleep and immunity
(i.e. disruption of Processes C and S results in impaired
immune function), a forced alteration in sleep timing/
duration may not be the same as natural/habitual short
sleep that satisfies homeostatic requirements. For
instance, sleep deprivation may disrupt both the normal
physiological purposes of sleep and affect molecular cues
for initiating and enforcing sleep.Current Opinion in Neurobiology 2013, 23:873–879
878 Circadian rhythm and sleepAs an alternative viewpoint, here we propose that Pro-
cesses C, Process S and certain immune responses (that
may contribute to the physiological necessity of sleep)
share molecular components such as PER2 and DEC2. As
FASP and FNSS models exhibit stable and inherent
alterations of sleep timing and duration, the characteriz-
ation of their immune responses may address this hypoth-
esis. Furthermore, identification of novel genes for FASP
and FNSS may provide additional molecular correlates
for sleep timing and duration beyond PER2 and DEC2.
Ultimately, physiological reasons for sleep and regulation
of sleep itself may require a delicate balance of shared
molecular events. Therefore, tuning these pathways
using both KO/haploinsufficient animals (loss-of-func-
tion) and transgenic mice carrying human mutations
(gain-of-function) may reveal the answers to age-old
questions of how, when, and why we sleep.
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